NeuroPace (NPCE) Depreciation and Depletion (2020 - 2026)
NeuroPace's (NPCE) quarterly Depreciation and Depletion came in at $60000.0 in Q1 2026, up 22.45% year-on-year from $49000.0 in Q1 2025, and up 42.86% quarter-over-quarter from $42000.0 in Q4 2025.
NeuroPace (NPCE) Depreciation and Depletion (2020 - 2026) Analysis & Trends
NeuroPace's Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $60000.0 for Q1 2026.
- On a quarterly basis, Depreciation and Depletion rose 22.45% year-over-year to $60000.0 in Q1 2026; TTM through Mar 2026 was $302000.0, a 4.14% increase from a year earlier, with the FY2025 full-year figure at $200000.0, changed 0.0% from the prior year.
- Depreciation and Depletion rose to $60000.0 in Q1 2026 per NPCE's latest filing, from $42000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $100000.0 in Q1 2022 and bottomed at $40000.0 in Q4 2023.
- The 5-year median for Depreciation and Depletion is $100000.0 (2022), against an average of $76000.0.
- Across the five-year window, Depreciation and Depletion surged 35.14% in 2022 and slumped 52.0% in 2023, its largest moves.
- Year by year, Depreciation and Depletion stood at $67000.0 in 2022, then slumped by 40.3% to $40000.0 in 2023, then rose by 2.5% to $41000.0 in 2024, then rose by 2.44% to $42000.0 in 2025, then surged by 42.86% to $60000.0 in 2026.
- Per Business Quant, the three latest NPCE Depreciation and Depletion figures stand at $60000.0 (Q1 2026), $42000.0 (Q4 2025), and $100000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Dec 31, 2023 | 40,000.00 |